Searched for
BADDI DABUR
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 26%Despite the US and Iran failing to reach an agreement over the weekend, the street is not entirely in a bearish mood. Market breadth is not...- Prices of raw material inputs the highest ever in three decades: Sunil Agarwal, chairman, RSH GlobalSo far, the maker of skin care brand Joy has been absorbing the price increase on raw and packaging materials which it notes as the highest...
- Consumer companies call on government for allowing manufacturing of essentials in red zonesDabur India, maker of Real juice and Vatika shampoo, said while recent guidelines issued by the Ministry of Home Affairs will definitely he...
- Consumer biz could bounce back in 3 months but restaurant business to take longer: Amit BurmanWe have to take a hit in the short term but in the long term, it will be good for us, says Dabur India Chairman.
- Super Vasmol to be sold, Founders eye up to ₹1,800 crLeading personal care companies Godrej Consumer Products Ltd, Marico, Emami, Dabur and HUL have been tapped as the founding family behind S...
- Johnson & Johnson resumes production of talc in India after regulators find no evidence of asbestosJ&J's talc came under controversy once again in India when Indian drug regulators ordered the testing of the talc to check if it contained ...
- Manjushree Technopak acquires Varahi Polymers; deal estimated at Rs 350 croreThis is Manjushree Technopack’s first acquisition and will pit it directly against multinational packaging company Tetrapak.
- Dabur takes up import alert issue with US FDADabur said the products on which US FDA has issued import alerts were unauthorised exports by an independent exporter and the company has t...
- Alembic Pharma to invest Rs 100 crore in new facilityAlembic Pharmaceuticals, the newly-listed subsidiary of the 104-year Vadodara-headquartered group, will invest Rs 100 crore in a drugs faci...
- Reckitt to absorb top Paras executivesReckitt Benckiser would absorb top 10 executives of Paras Pharmaceuticals and retain 200 people working at its Baddi plant in an in-princip...
- Emami expects 15-20% growth in Chyawanprash segmentFMCG firm Emami is expecting a 15-20 per cent growth in its Chyawanprash segment even as its plans to consolidate all its brands under the ...
- Germany's Fresenius recalls India-made drugs shipped to USGerman drug co recalled two batches of cancer drug made by its Indian arm on cross-contamination.
- Emami keen on Paras Pharma stake; Godrej, GSKCH deny talksPrivate equity firms Actis and Sequoia that together hold 70% stake are looking to sell their holding at an estimated price of $700 mn.
- Dabur ties up with Belgium firm to reduce carbon emissionFMCG major Dabur on Tuesday said it has tied up with a Belgium firm for technical collaboration to reduce carbon emissions in its plants an...
- Dabur bags Fem Care for Rs 204 crDabur India on Friday announced the acquisition of 72.15% of women’s skin-care company Fem Care Pharma (FCPL) for Rs 203.7 crore in an all-...
- Fresenius Kabi to invest 30 mn euros in Dabur’s API plantFresenius Kabi, which acquired the Burmans’ pharma business early this year, will invest around 30 euros million in the active pharmaceutic...
- Fresenius to invest 30 mn euro in DaburFresenius Kabi, which acquired Dabur Pharma, is looking to expand the latter's oncology business globally with plans of investing up to 30 ...
- German co Fresenius Kabi picks up 73% in Dabur PharmaGerman co Fresenius Kabi acquired the stake in Dabur Pharma for around Rs 872 cr. With this, the Burman family exits pharmaceutical biz. Go...
- Dabur Pharma forays into Pak anti-cancer drug mktStepping up its overseas expansion, Dabur Pharma has made a foray into the anti-cancer drug market in Pakistan and Turkmenistan.
- Dabur Pharma Q4 net up 13 foldSpurred by better product mix and controlled expenses in manufacturing, Dabur Pharma's net profit in the fourth quarter ended March 31 grew...
Load More
